Efficacy and safety of curcumin in maintaining remission during disease-modifying antirheumatic drug withdrawal in rheumatoid arthritis at 52 weeks: a phase III double-blind, randomized placebo-controlled trial

Curcumin has anti-inflammatory properties but current evidence is limited to advocate its use in rheumatoid arthritis (RA). We explored whether curcumin could maintain remission in patients with RA while tapering conventional synthetic Disease-Modifying Antirheumatic Drugs (csDMARD). In this patient...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatology international 2023-12, Vol.43 (12), p.2193-2200
Hauptverfasser:	Bhat, Sreeja S., Ahmed, Sakir, Reji, Reshma, Mehta, Pankti, Paul, Aby, Mohanan, Manju, Babu, Sageer, Vinayak, Biju, Vijayan, Anuroopa, Nalianda, Kaveri K., Joseph, Sanjana, Narayanan, K., Padmaja, R., Alex, Glaxon, Shenoy, Padmanabha
Format:	Artikel
Sprache:	eng
Schlagworte:	Clinical Trials Double-blind studies Medicine Medicine & Public Health Remission (Medicine) Rheumatoid arthritis Rheumatology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!